Inactive Instrument

Immunosyn Corp Share Price

Stocks

End-of-day quote Other OTC Other stock markets
- ^USD	-

29/11/-1	IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	PR
29/11/-1	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	PR
29/11/-1	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	PR
29/11/-1	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	PR
29/11/-1	Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	PR

Manager	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	75	14/10/2007
Douglas A. McClain DFI	Director of Finance/CFO	51	-

Director	Title	Age	Since
Stephen D. Ferrone BRD	Director/Board Member	75	08/07/2011
Douglas A. McClain CHM	Chairman	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+0.63%	-3.06%	+16.50%	-10.25%	66.74B
UCB	-0.28%	+3.07%	+37.15%	+203.36%	53.32B
SAMSUNG BIOLOGICS CO.,LTD.	+10.08%	+51.80%	+51.80%	+51.80%	48.12B
CSL LIMITED	+1.90%	-5.07%	-56.99%	-56.52%	38.25B
BIOGEN INC.	+0.78%	-1.84%	+53.73%	-23.77%	29.85B
INCYTE CORPORATION	+0.84%	+0.36%	+67.62%	+87.37%	23.51B
MODERNA, INC.	-5.17%	-12.54%	+58.33%	-55.18%	21.45B
BRIDGEBIO PHARMA, INC.	+1.31%	+3.24%	+81.47%	+159.24%	16.47B
SWEDISH ORPHAN BIOVITRUM AB	-0.31%	-1.21%	+62.31%	+123.56%	16.38B
Average	+1.09%	-0.72%	+41.33%	+53.29%	34.9B
Weighted average by Cap.	+1.70%	+0.01%	+32.48%	+48.70%

Employees

Sector